 |
The Journal of Neuroscience, November 1, 2006, 26(44):11397-11402; doi:10.1523/JNEUROSCI.0602-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Absence of Tumor Necrosis Factor- Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations
Geneviève Gowing,
Florence Dequen,
Geneviève Soucy, and
Jean-Pierre Julien
Laboratory of Molecular Endocrinology, Centre de Recherche du Centre Hospitalier de l'Université Laval Research Center, and Department of Anatomy and Physiology, Laval University 2705, Québec, Canada G1V 4G2
Correspondence should be addressed to Jean-Pierre Julien at the above address. E-mail: Email: jean-pierre.julien{at}crchul.ulaval.ca
An increase in the expression of the proinflammatory cytokine tumor necrosis factor (TNF- ) has been observed in patients with amyotrophic lateral sclerosis (ALS) and in the mice models of the disease. TNF- is a potent activator of macrophages and microglia and, under certain conditions, can induce or exacerbate neuronal cell death. Here, we assessed the contribution of TNF- in motor neuron disease in mice overexpressing mutant superoxide dismutase 1 (SOD1) genes linked to familial ALS. This was accomplished by the generation of mice expressing SOD1G37R or SOD1G93A mutants in the context of TNF- gene knock out. Surprisingly, the absence of TNF- did not affect the lifespan or the extent of motor neuron loss in SOD1 transgenic mice. These results provide compelling evidence indicating that TNF- does not directly contribute to motor neuron degeneration caused by SOD1 mutations.
Key words: ALS; amyotrophic lateral sclerosis; degeneration; microglia; motoneuron; motor neuron; neuroinflammation; TNF-
Received Feb. 10, 2006;
revised Sept. 22, 2006;
accepted Sept. 25, 2006.
Correspondence should be addressed to Jean-Pierre Julien at the above address. E-mail: Email: jean-pierre.julien{at}crchul.ulaval.ca
This article has been cited by other articles:

|
 |

|
 |
 
N. D'Ambrosi, P. Finocchi, S. Apolloni, M. Cozzolino, A. Ferri, V. Padovano, G. Pietrini, M. T. Carri, and C. Volonte
The Proinflammatory Action of Microglial P2 Receptors Is Enhanced in SOD1 Models for Amyotrophic Lateral Sclerosis
J. Immunol.,
October 1, 2009;
183(7):
4648 - 4656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gowing, T. Philips, B. Van Wijmeersch, J.-N. Audet, M. Dewil, L. Van Den Bosch, A. D. Billiau, W. Robberecht, and J.-P. Julien
Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase
J. Neurosci.,
October 8, 2008;
28(41):
10234 - 10244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Barrette, M.-A. Hebert, M. Filali, K. Lafortune, N. Vallieres, G. Gowing, J.-P. Julien, and S. Lacroix
Requirement of Myeloid Cells for Axon Regeneration
J. Neurosci.,
September 17, 2008;
28(38):
9363 - 9376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kang and S. Rivest
MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis
J. Cell Biol.,
December 17, 2007;
179(6):
1219 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Gibb, W. Boston-Howes, Z. S. Lavina, S. Gustincich, R. H. Brown Jr., P. Pasinelli, and D. Trotti
A Caspase-3-cleaved Fragment of the Glial Glutamate Transporter EAAT2 Is Sumoylated and Targeted to Promyelocytic Leukemia Nuclear Bodies in Mutant SOD1-linked Amyotrophic Lateral Sclerosis
J. Biol. Chem.,
November 2, 2007;
282(44):
32480 - 32490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lu, L. Zheng, L. Viera, E. Suswam, Y. Li, X. Li, A. G. Estevez, and P. H. King
Mutant Cu/Zn-Superoxide Dismutase Associated with Amyotrophic Lateral Sclerosis Destabilizes Vascular Endothelial Growth Factor mRNA and Downregulates Its Expression
J. Neurosci.,
July 25, 2007;
27(30):
7929 - 7938.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|